Restricted accessResearch articleFirst published online 2011-2
Incremental value of T2-weighted and diffusion-weighted MRI for prediction of biochemical recurrence after radical prostatectomy in clinically localized prostate cancer
For men with clinically localized prostate cancer and candidates to receive radical prostatectomy (RP) a main concern is a cancer recurrence after treatment. Although previous studies have demonstrated the diagnostic utility of diffusion-weighted imaging (DWI) for prostate cancer, the prognostic value of pretreatment DWI has not been investigated yet.
Purpose
To investigate the incremental value of MRI-based T staging using DWI and T2-weighted imaging (T2WI) as compared with the clinical parameters in prediction of biochemical recurrence (BCR) after RP for clinically localized prostate cancer.
Material and Methods
Sixty MR examinations, obtained before RP between April 2002 and March 2009, were retrospectively reviewed using T2WI alone, DWI alone, or T2WI + DWI for T staging according to the 2002 American Joint Committee on Cancer guidelines. The relationship between MRI stage and BCR was evaluated using Kaplan-Meier survival estimates. Multivariate analysis and receiver operating characteristics (ROC) curve analysis were used to investigate the incremental value over the standard clinical variables in prediction of BCR.
Results
As of August 2009, 12 (20%) patients had BCR. Based on T2WI + DWI, both T3a (compared to OC disease) and T2 (compared to T1c) showed significantly higher BCR rates (p = 0.047 and 0.025, respectively). Multivariate analysis and area under ROC curve analysis confirmed the additional value of MRI staging to the conventional clinical variables in prediction of BCR.
Conclusion
The combination of T2WI and DWI on performing pretreatment MRI helped predict BCR after RP in clinically localized prostate cancer.
HanM, PartinAW, ZahurakM, Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol2003;169:517–23
2.
KattanMW, EasthamJA, StapletonAM, A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst1998;90:766–71
3.
StephensonAJ, ScardinoPT, EasthamJA, Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst2006;98:715–7
4.
HeenanSD. Magnetic resonance imaging in prostate cancer. Prostate Cancer Prostatic Dis2004;7:282–8
5.
QayyumA, CoakleyFV, LuY, Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. Am J Roentgenol2004;183:1079–83
ChoiYJ, KimJK, KimN, Functional MR imaging of prostate cancer. Radiographics2007;27:63–75
8.
KimJK, HongSS, ChoiYJ, Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization. J Magn Reson Imaging2005;22:639–46
9.
IssaB. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging2002;16:196–200
10.
HosseinzadehK, SchwarzSD. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging2004;20:654–61
11.
PicklesMD, GibbsP, SreenivasM, Diffusion-weighted imaging of normal and malignant prostate tissue at 3.0 T. J Magn Reson Imaging2006;23:130–4
12.
GibbsP, PicklesMD, TurnbullLW. Diffusion imaging of the prostate at 3.0 Tesla. Invest Radiol2006;41:185–8
13.
KozlowskiP, ChangSD, JonesEC, Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis—correlation with biopsy and histopathology. J Magn Reson Imaging2006;24:108–13
14.
TamadaT, SoneT, JoY, Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade. J Magn Reson Imaging2008;28:720–6
15.
SatoC, NaganawaS, NakamuraT, Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging2005;21:258–62
16.
KimCK, ParkBK, LeeHM, Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results. Invest Radiol2007;42:842–7
17.
ChanI, WellsW3rdMulkernRV, Detection of prostate cancer by integration of line-scan diffusion, T2-mapping and T2-weighted magnetic resonance imaging; a multichannel statistical classifier. Med Phys2003;30:2390–8
18.
LimHK, KimJK, KimKA, Prostate Cancer: Apparent Diffusion Coefficient Map With T2-Weighted Images for Detection – A Multireader Study. Radiology2009;250:145–51
19.
HaiderMA, van der KwastTH, TanguayJ, Combind T2-weighted and diffusion-weighted MRI for localization of prostate cancer. Am J Roentgenol2007;189:323–8
20.
D'AmicoAV, WhittingtonR, MalkowiczB, Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer. J Urol2000;164:759–63
21.
ManzoneTA, MalkowiczSB, TomaszewskiJE, Use of endorectal MR imaging to predict prostate carcinoma recurrence after radical prostatectomy. Radiology1998;209:537–42
22.
ChengGC, ChenMH, WhittingtonR, Clinical utility of endorectal MRI in determining PSA outcome for patients with biopsy Gleason score 7, PSA <or = 10, and clinically localized prostate cancer. Int J Radiat Oncol Biol Phys2003;55:64–70
23.
FuchsjägerMH, Shukla-DaveA, HricakH, Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy. BJU Int2009;104:315–20
24.
PoulakisV, WitzschU, de VriesR, Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and gleason score for predicting prostate cancer biochemical recurrence after radical prostatectomy. Urology2004;64:1165–70
25.
Shukla-DaveA, HricakH, IshillN, Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profiles. Clin Cancer Res2009;15:3842–9
26.
WhiteS, HricakH, ForstnerR, Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology1995;195:385–90
CooksonMS, AusG, BurnettAL, Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol2007;177:540–5
29.
AkinO, SalaE, MoskowitzCS, Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology2006;239:784–92
GreeneFL. Prostate. In: GreeneFL, PageDL, FlemingID, eds. AJCC Cancer Staging Manual. 6th edn.New York, NY: Springer-Verlag2002:309–16
32.
YuKK, ScheidlerJ, HricakH, Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology1999;213:481–8
33.
DorfmanDD, BerbaumKS, MetzCE. Receiver operating characteristic rating analysis: Generalization to the population of readers and patients with the jackknife method. Investigative Radiology1992;27:723–31
34.
GibbsP, LineyGP, PicklesMD, Correlation of ADC and T2 Measurements With Cell Density in Prostate Cancer at 3.0 Tesla. Investigative Radiology2009;44:572–6
35.
WangXZ, WangB, GaoZQ, Diffusion-weighted imaging of prostate cancer: correlation between apparent diffusion coefficient values and tumor proliferation. J Magn Reson Imaging2009;29:1360–6
